CoChat

Photodegradation of Lipofuscin in Suspension and in ARPE-19 Cells and the Similarity of Fluorescence of the Photodegradation Product with Oxidized Docosahexaenoate

Open access
Różanowska, Małgorzata B., Różanowski, Bartosz · 2022 · International Journal of Molecular Sciences

Published version of a preprint

The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Retinal lipofuscin accumulates with age in the retinal pigment epithelium (RPE), where its fluorescence properties are used to assess retinal health. It was observed that there is a decrease in lipofuscin fluorescence above the age of 75 years and in the early stages of age-related macular degeneration (AMD). The purpose of this study was to investigate the response of lipofuscin isolated from human RPE and lipofuscin-laden cells to visible light, and to determine whether an abundant component of lipofuscin, docosahexaenoate (DHA), can contribute to lipofuscin fluorescence upon oxidation. Exposure of lipofuscin to visible light leads to a decrease in its long-wavelength fluorescence at about 610 nm, with a concomitant increase in the short-wavelength fluorescence. The emission spectrum of photodegraded lipofuscin exhibits similarity with that of oxidized DHA. Exposure of lipofuscin-laden cells to light leads to a loss of lipofuscin granules from cells, while retaining cell viability. The spectral changes in fluorescence in lipofuscin-laden cells resemble those seen during photodegradation of isolated lipofuscin. Our results demonstrate that fluorescence emission spectra, together with quantitation of the intensity of long-wavelength fluorescence, can serve as a marker useful for lipofuscin quantification and for monitoring its oxidation, and hence useful for screening the retina for increased oxidative damage and early AMD-related changes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23020922

Cites

106 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Irradiation of lipofuscin with visible light results in a decrease in long-wavelength fluorescence and an increase in short-wavelength fluorescence. Representative fluorescence emission spectra of lipofuscin granules suspended in PBS before and after indicated time of irradiation with visible light (9.76 mW/cm2) upon excitation with 360 nm (A) and 488 nm (B) light. (C) Fluorescence emission spectra from (B), corrected for the spectral changes in sensitivity of the detector, demonstrate that the emission maximum corresponds to the emission maximum of RPE lipofuscin, at about 600 nm. Kinetics of changes of fluorescence emission intensity monitored at indicated wavelengths, normalized to the value before irradiation and expressed as percentage (D,E) and changes in fluorescence intensity ratios at indicated wavelengths (F,G) during irradiation with 9.76 mW/cm2 visible light. Fluorescence was induced by excitation with 360 nm (D,F) or 488 nm (E,G) light. The ratios of fluorescence intensities were calculated based on uncorrected spectra in the case of excitation at 360 nm and on corrected spectra in the case of excitation at 488 nm. Fluorescence of the solvent (PBS) was recorded to show its Raman emission peaks.
Figure 1 Irradiation of lipofuscin with visible light results in a decrease in long-wavelength fluorescence and an increase in short-wavelength fluorescence. Representative fluorescence emission spectra of lipofuscin granules suspended in PBS before and after indicated time of irradiation with visible light (9.76 mW/cm2) upon excitation with 360 nm (A) and 488 nm (B) light. (C) Fluorescence emission spectra from (B), corrected for the spectral changes in sensitivity of the detector, demonstrate that the emission maximum corresponds to the emission maximum of RPE lipofuscin, at about 600 nm. Kinetics of changes of fluorescence emission intensity monitored at indicated wavelengths, normalized to the value before irradiation and expressed as percentage (D,E) and changes in fluorescence intensity ratios at indicated wavelengths (F,G) during irradiation with 9.76 mW/cm2 visible light. Fluorescence was induced by excitation with 360 nm (D,F) or 488 nm (E,G) light. The ratios of fluorescence intensities were calculated based on uncorrected spectra in the case of excitation at 360 nm and on corrected spectra in the case of excitation at 488 nm. Fluorescence of the solvent (PBS) was recorded to show its Raman emission peaks.CC BY · PubMed Central
Figure 2 Fluorescence emission of oxidized docosahexaenoate (OxDHA) may contribute to the emission of photodegraded lipofuscin. Representative fluorescence emission spectra of oxDHA and photodegraded lipofuscin (LF) granules obtained by excitation with 360 nm (A) and 488 nm (B) light. (C) Fluorescence emission spectra from (B) corrected for the spectral changes in sensitivity of the detector. Prior to fluorescence measurement, lipofuscin was photodegraded by irradiation for 10.5 h with 9.76 mW/cm2 visible light providing radiant exposure of 369 J/cm2. OxDHA was obtained by auto-oxidation of phosphatidylcholine with two DHA acyl chains. The concentration of OxDHA used for fluorescence measurements corresponds to 4.23 mg/mL of the non-oxidized phospholipid.
Figure 2 Fluorescence emission of oxidized docosahexaenoate (OxDHA) may contribute to the emission of photodegraded lipofuscin. Representative fluorescence emission spectra of oxDHA and photodegraded lipofuscin (LF) granules obtained by excitation with 360 nm (A) and 488 nm (B) light. (C) Fluorescence emission spectra from (B) corrected for the spectral changes in sensitivity of the detector. Prior to fluorescence measurement, lipofuscin was photodegraded by irradiation for 10.5 h with 9.76 mW/cm2 visible light providing radiant exposure of 369 J/cm2. OxDHA was obtained by auto-oxidation of phosphatidylcholine with two DHA acyl chains. The concentration of OxDHA used for fluorescence measurements corresponds to 4.23 mg/mL of the non-oxidized phospholipid.CC BY · PubMed Central
Figure 3 Exposure of lipofuscin-laden ARPE-19 cells to 9.76 mJ/cm2 visible light results in exocytosis of packeted lipofuscin granules and spectral changes in lipofuscin fluorescence. Representative images from phase-contrast/bright-field and fluorescence microscopy of ARPE-19 cells supplemented with lipofuscin granules 3 times per week over a period of 32 days (13 times in total) and imaged on day 32 (LF); after additional 14 days in dark with daily media change and incubation for 45 min with PBS (LF, 14 days dark); after additional 3 days which included two 45 min exposures to visible light and images were focused either on cells or vesicles floating above them (LF, 2 × Light, cells; LF, 2 × Light, vesicles). The yellow arrows in the phase-contrast image with 100× magnification point to the packeted lipofuscin floating above the cell monolayer, and images on the right show fluorescence from the cell monolayer (LF, 2 × Light, cells). The row below shows images focused on the packeted lipofuscin in bright-field or fluorescence mode (LF, 2 × Light, vesicles); after 15 days with 14 daily exposures to visible light (LF, 14 × Light). The bottom two rows show cells not supplemented with lipofuscin but treated in the same ways as the supplemented cells with light (NoLF, 14 × Light) or in dark (NoLF, 14 days dark). Fluorescence images were acquired with colour camera capturing the colour of lipofuscin fluorescence as it appears to the human eye (Total Fluorescence). The gain used for collecting fluorescence images was two-fold smaller for lipofuscin-laden cells not exposed to light (LF; LF, 14 days dark) than for all other cells. Unless stated otherwise, magnification was 400×. The images were opened in ImageJ as an RGB stack to quantify the green (Green Fluorescence) and red (Red Fluorescence) fluorescence.
Figure 3 Exposure of lipofuscin-laden ARPE-19 cells to 9.76 mJ/cm2 visible light results in exocytosis of packeted lipofuscin granules and spectral changes in lipofuscin fluorescence. Representative images from phase-contrast/bright-field and fluorescence microscopy of ARPE-19 cells supplemented with lipofuscin granules 3 times per week over a period of 32 days (13 times in total) and imaged on day 32 (LF); after additional 14 days in dark with daily media change and incubation for 45 min with PBS (LF, 14 days dark); after additional 3 days which included two 45 min exposures to visible light and images were focused either on cells or vesicles floating above them (LF, 2 × Light, cells; LF, 2 × Light, vesicles). The yellow arrows in the phase-contrast image with 100× magnification point to the packeted lipofuscin floating above the cell monolayer, and images on the right show fluorescence from the cell monolayer (LF, 2 × Light, cells). The row below shows images focused on the packeted lipofuscin in bright-field or fluorescence mode (LF, 2 × Light, vesicles); after 15 days with 14 daily exposures to visible light (LF, 14 × Light). The bottom two rows show cells not supplemented with lipofuscin but treated in the same ways as the supplemented cells with light (NoLF, 14 × Light) or in dark (NoLF, 14 days dark). Fluorescence images were acquired with colour camera capturing the colour of lipofuscin fluorescence as it appears to the human eye (Total Fluorescence). The gain used for collecting fluorescence images was two-fold smaller for lipofuscin-laden cells not exposed to light (LF; LF, 14 days dark) than for all other cells. Unless stated otherwise, magnification was 400×. The images were opened in ImageJ as an RGB stack to quantify the green (Green Fluorescence) and red (Red Fluorescence) fluorescence.CC BY · PubMed Central
Figure 4 Supplementation with antioxidants of lipofuscin-laden ARPE-19 cells during 14 daily exposures to 9.76 mJ/cm2 visible light does not affect loss of lipofuscin granules or spectral changes in fluorescence. Representative images from phase-contrast and fluorescence microscopy of lipofuscin-laden ARPE-19 cells after 14 daily exposures to visible light in the absence (LF + 14 × Light) and presence of N-acetyl cysteine (NAC) or lipoic acid (LPA). Other experimental conditions as in Figure 3.
Figure 4 Supplementation with antioxidants of lipofuscin-laden ARPE-19 cells during 14 daily exposures to 9.76 mJ/cm2 visible light does not affect loss of lipofuscin granules or spectral changes in fluorescence. Representative images from phase-contrast and fluorescence microscopy of lipofuscin-laden ARPE-19 cells after 14 daily exposures to visible light in the absence (LF + 14 × Light) and presence of N-acetyl cysteine (NAC) or lipoic acid (LPA). Other experimental conditions as in Figure 3.CC BY · PubMed Central
Figure 5 Quantification of area occupied by lipofuscin in phase-contrast images (left panel) and intensity of green and red fluorescence (right panel) from experiments for which the representative images are shown in Figure 3 and Figure 4. LF: lipofuscin-laden cells maintained for additional 15 days with 14 daily media changes and 45 min incubations with PBS; dLF: lipofuscin-laden cells maintained for additional 15 days with 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light; dLF+LPA: as dLF but exposures to light were in the presence of 0.1 mM lipoic acid; dLF+NAC: as dLF but exposures to light were in the presence of 0.2 mM N-acetyl cysteine; noLF: as dLF but cells were subjected to sham treatment instead of supplementation with lipofuscin and exposure to light. The circles and triangles represent data from different experiments; the crosses represent the means; the error bars represent SDs.
Figure 5 Quantification of area occupied by lipofuscin in phase-contrast images (left panel) and intensity of green and red fluorescence (right panel) from experiments for which the representative images are shown in Figure 3 and Figure 4. LF: lipofuscin-laden cells maintained for additional 15 days with 14 daily media changes and 45 min incubations with PBS; dLF: lipofuscin-laden cells maintained for additional 15 days with 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light; dLF+LPA: as dLF but exposures to light were in the presence of 0.1 mM lipoic acid; dLF+NAC: as dLF but exposures to light were in the presence of 0.2 mM N-acetyl cysteine; noLF: as dLF but cells were subjected to sham treatment instead of supplementation with lipofuscin and exposure to light. The circles and triangles represent data from different experiments; the crosses represent the means; the error bars represent SDs.CC BY · PubMed Central
Figure 6 Representative fluorescence emission spectra from ARPE-19 cells solubilized in Triton X-100. Cells were treated as in Figure 3 and Figure 4. Fluorescence was induced by photoexcitation with 360 nm (A) or 488 nm (B) light. (C) Fluorescence emission spectra from (B), corrected for the spectral changes in sensitivity of the detector. Confluent cells were supplemented with lipofuscin (LF) or sham-treated (no LF) for 32 days followed by 15 days with 14 daily media changes and 45 min incubations with PBS in dark (dark) or 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light (light). Cells in selected wells were exposed to light in the presence of 0.1 mM lipoic acid (LPA) or 0.2 mM N-acetyl cysteine (NAC). Green line shows Raman emission peak from solvent, 1% Triton X-100 in PBS (Tx in PBS).
Figure 6 Representative fluorescence emission spectra from ARPE-19 cells solubilized in Triton X-100. Cells were treated as in Figure 3 and Figure 4. Fluorescence was induced by photoexcitation with 360 nm (A) or 488 nm (B) light. (C) Fluorescence emission spectra from (B), corrected for the spectral changes in sensitivity of the detector. Confluent cells were supplemented with lipofuscin (LF) or sham-treated (no LF) for 32 days followed by 15 days with 14 daily media changes and 45 min incubations with PBS in dark (dark) or 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light (light). Cells in selected wells were exposed to light in the presence of 0.1 mM lipoic acid (LPA) or 0.2 mM N-acetyl cysteine (NAC). Green line shows Raman emission peak from solvent, 1% Triton X-100 in PBS (Tx in PBS).CC BY · PubMed Central
Figure 7 Lipofuscin and/or fractionated exposure to 9.76 mW/cm2 visible light does not affect viability or endocytic activity of ARPE-19 cells. (A) Cell viability measured by MTT assay. (B) Endocytic activity was measured by neutral red assay. Confluent cells were supplemented with lipofuscin (LF) or sham-treated (no LF) for 32 days followed by 15 days with 14 daily media changes and 45 min incubations with PBS in dark (dark) or 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light (light). Cells in selected wells were exposed to light in the presence of 0.1 mM lipoic acid (LPA) or 0.2 mM N-acetyl cysteine (NAC). The assays were performed a day after the 14th exposure to light/dark. The absorbance values were normalized to the value obtained in cells not supplemented with lipofuscin and maintained in dark. The height of the bar indicates the mean of three experiments, while the error bar indicates SD. One-way analysis of variance (ANOVA) showed no significant differences between any groups.
Figure 7 Lipofuscin and/or fractionated exposure to 9.76 mW/cm2 visible light does not affect viability or endocytic activity of ARPE-19 cells. (A) Cell viability measured by MTT assay. (B) Endocytic activity was measured by neutral red assay. Confluent cells were supplemented with lipofuscin (LF) or sham-treated (no LF) for 32 days followed by 15 days with 14 daily media changes and 45 min incubations with PBS in dark (dark) or 14 daily media changes and 45 min exposures to 9.76 mJ/cm2 visible light (light). Cells in selected wells were exposed to light in the presence of 0.1 mM lipoic acid (LPA) or 0.2 mM N-acetyl cysteine (NAC). The assays were performed a day after the 14th exposure to light/dark. The absorbance values were normalized to the value obtained in cells not supplemented with lipofuscin and maintained in dark. The height of the bar indicates the mean of three experiments, while the error bar indicates SD. One-way analysis of variance (ANOVA) showed no significant differences between any groups.CC BY · PubMed Central
Figure 8 Irradiance spectrum of light used for photodegradation of lipofuscin and exposure to light of ARPE-19 cells.
Figure 8 Irradiance spectrum of light used for photodegradation of lipofuscin and exposure to light of ARPE-19 cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 108 references

Research works printed but not linked: 1

  1. Halliwell, B., and Gutteridge, J.M.C. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].

Cited by

Metadata

Authors
Różanowska, M. B., & Różanowski, B.
Affiliations
  • School of Optometry and Vision Sciences, Cardiff University, Cardiff CF24 4HQ, UK
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie (PL)
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-01-15
Volume
23
Issue
2
Pages
922
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4225997505
Cited by
14
References
105
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 3
FWCI
2.46
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wellcome Trust (ISSF3 Cardiff University)
  • Cardiff University (School of Optometry and Vision Sciences Research Development Fund)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Keywords
lipofuscin, photodegradation, docosahexaenoic acid, retinal pigment epithelium, ARPE-19 cells, age-related macular degeneration, oxidative damage, visible light exposure, lipofuscin granules
MeSH terms
Cell Line, Cell Survival, Docosahexaenoic Acids, Endocytosis, Humans, Light, Lipofuscin, Microscopy, Fluorescence, Oxidation-Reduction, Photolysis, Retinal Pigment Epithelium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.